Zentalis Pharmaceuticals (ZNTL) Net Income - Minority (2020 - 2023)
Zentalis Pharmaceuticals' quarterly Net Income - Minority came in at -$107000.0 in Q4 2023, up 51.58% year-on-year from -$70588.1 in Q4 2022, and up 17.05% quarter-over-quarter from -$129000.0 in Q3 2023.
Zentalis Pharmaceuticals has reported Net Income - Minority for 4 years, with the latest figure at -$107000.0 in Q4 2023.
- For the quarter ending Q4 2023, Net Income - Minority rose 51.58% year-over-year to -$107000.0; the trailing twelve-month figure through Dec 2023 stood at -$107000.0 (up 51.58% YoY), and the FY2023 full-year result was -$107000.0, up 51.58% from the prior year.
- Net Income - Minority for Q4 2023 stood at -$107000.0, up from -$129000.0 in the prior quarter.
- The five-year high for Net Income - Minority was -$107000.0 in Q4 2023, with the low at -$24.8 million in Q4 2020.
- Average Net Income - Minority over 4 years is -$3.7 million, with a median of -$178000.0 recorded in 2023.
- Year-over-year, Net Income - Minority surged 97.87% in 2021 and jumped 51.58% in 2023.
- Tracing ZNTL's Net Income - Minority over 4 years: stood at -$24.8 million in 2020, then surged by 97.87% to -$528000.0 in 2021, then soared by 58.14% to -$221000.0 in 2022, then jumped by 51.58% to -$107000.0 in 2023.
- The last three Net Income - Minority figures came in at -$107000.0 (Q4 2023), -$129000.0 (Q3 2023), and -$141000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -107,000.00 |
| Sep 30, 2023 | -129,000.00 |
| Jun 30, 2023 | -141,000.00 |
| Mar 31, 2023 | -178,000.00 |
| Dec 31, 2022 | -221,000.00 |
| Dec 31, 2021 | -528,000.00 |
| Dec 31, 2020 | -24.80 Mn |